Literature DB >> 8728311

Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway.

M Fernández-Borja1, D Bellido, E Vilella, G Olivecrona, S Vilaró.   

Abstract

Lipoprotein lipase (LPL), a key enzyme in lipoprotein triglyceride metabolism, produces a marked increase in the retention and uptake of all classes of lipoproteins by cultured cells. It was previously shown that two different receptors are involved in mediating the LPL effects: heparan sulfate proteoglycans (HSPG) and the low density lipoprotein (LDL) receptor-related protein/alpha 2 macroglobulin receptor (LRP). By immunofluorescence we show here that cell surface-bound LPL displays a pattern that corresponds to the previously described distribution of cell surface HSPG. No evident relation to the distribution of bound activated alpha 2-macroglobulin (alpha 2M*) or to LRP was observed. By immunoelectron microscopy we found that after 30 min at 37 degrees C most of the detected alpha 2M* (70% of the total gold particles) was inside the cells and associated with endosomal vesicles. However, at the same time, 76% of the LPL remained at the cell surface, suggesting that, LPL is internalized by a slow endocytic process. Binding of triglyceride-rich lipoproteins (TRL) or LDL together with LPL led to a spectacular increase in bound lipoproteins, which completely colocalized with LPL. After incubation at 37 degrees C, LPL and 1,1'-dioctadecyl-3,3,3,'3'-tetramethylindocarbocyanine (DiI)-TRL formed large clusters on the cell surface. Immunofluorescene and quantitative immunoelectron microscopy provided evidence of co-internalization of LPL and apoE-containing TRL by a slow endocytic process. In the absence of LPL, the fibroblasts rapidly internalized DiI-LDL and showed fluorescence in central, lysosome-like vesicles. In contrast, when LPL was present, internalization of DiI-LDL involved small, widely distributed vesicles. This pattern slowly changed to one consisting of large perinuclear vesicles. LDL receptor-deficient fibroblasts internalized DiI-LDL, either with or without LPL, into small widely distributed vesicles and no central vesicles were seen. Chloroquine-treated normal fibroblasts internalized DiI-LDL in a pattern similar to that of receptor-deficient fibroblasts. Taken together our results suggest an alternative receptor-independent endocytosis pathway for LDL. This pathway is potentiated by LPL and is characterized by a slow uptake involving small vesicles that gradually reach lysosomes. We suggest that, through its interaction with HSPG, LPL provides high capacity binding sites for lipoproteins and a independent internalization pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8728311

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

Review 1.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

2.  Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins.

Authors:  B Halvorsen; U K Aas; M A Kulseth; C A Drevon; E N Christiansen; S O Kolset
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes.

Authors:  Kazuchika Nishitsuji; Takashi Hosono; Kenji Uchimura; Makoto Michikawa
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

4.  Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells.

Authors:  Shao-wei Sun; Xu-yu Zu; Qin-hui Tuo; Lin-xi Chen; Xiao-yong Lei; Kai Li; Chao-ke Tang; Duan-fang Liao
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

Review 5.  Metabolic disturbances in diabetic cardiomyopathy.

Authors:  B Rodrigues; M C Cam; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 6.  Lipoprotein lipase in the brain and nervous system.

Authors:  Hong Wang; Robert H Eckel
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

7.  Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

Authors:  J D Medh; G L Fry; S L Bowen; S Ruben; H Wong; D A Chappell
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

8.  Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity.

Authors:  Juliane G Strauss; Robert Zimmermann; Andelko Hrzenjak; Yonggang Zhou; Dagmar Kratky; Sanja Levak-Frank; Gert M Kostner; Rudolf Zechner; Sasa Frank
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.

Authors:  Larissa C Wilsie; Amanda M Gonzales; Robert A Orlando
Journal:  Lipids Health Dis       Date:  2006-08-31       Impact factor: 3.876

Review 10.  Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.

Authors:  Marcos Palacio Rojas; Carem Prieto; Valmore Bermúdez; Carlos Garicano; Trina Núñez Nava; María Sofía Martínez; Juan Salazar; Edward Rojas; Arturo Pérez; Paulo Marca Vicuña; Natalia González Martínez; Santiago Maldonado Parra; Kyle Hoedebecke; Rosanna D'Addosio; Clímaco Cano; Joselyn Rojas
Journal:  F1000Res       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.